Nerve-Zapping kidney procedure may boost heart rhythm treatment

NCT ID NCT05116384

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a kidney nerve-zapping procedure (renal artery denervation) to the standard heart ablation procedure can better control persistent atrial fibrillation (AF). About 50 adults with persistent AF and controlled or no high blood pressure will be randomly assigned to receive either standard ablation alone or ablation plus the kidney procedure. The main goal is to see if the combination reduces the total time spent in AF over the long term, measured by a heart monitor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

renal artery denervation (a procedure using radiofrequency energy to disrupt nerves in the kidney arteries) plus catheter ablation (using cryo energy to isolate pulmonary veins)

What this could lead to

If successful, this combination procedure could reduce the amount of time people with persistent atrial fibrillation spend in an irregular heart rhythm, potentially improving long-term outcomes.

What could go wrong

This is a small pilot study with only 50 participants, so results may not apply to everyone. The added procedure carries risks like blood vessel damage, and it is unclear if the benefit outweighs those risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Rochester

    RECRUITING

    Short Hills, New Jersey, 07078, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••